chrisvoncsefalvay/vaers-outcomes huggingface dataset:
slight soreness on Left bicep at injection site; Third Shot - Swollen and tender lymph nodes on the Left axillary area began 24-30 hours after injection. (same side as injection arm) slight soreness on Left bicep at injection site; Swollen and tender lymph nodes on the Left axillary area began 24-30 hours after injection. (same side as injection arm); Third Shot; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 39 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 05Dec2021 21:30 (Lot number: 33030bd) at the age of 39 years as dose 3 (booster), single for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included ACCUTANE. No Past drug history included. Vaccination history included: Bnt162b2 (Dose 2, Batch/Lot Number: EM9009, Location of injection: Arm Left, Vaccine Administration Time: 10:00, Left arm completely numb, sore, and unable to move for 24 hours, pain diminished after 72 hours.), administration date: 11Feb2021, for Covid-19 immunization, reaction(s): Left arm completely numb; Bnt162b2 (Dose 1, Batch/Lot Number: el8982, Location of injection: Arm Left, Vaccine Administration Time: 08:00, only slight bruise pain at injection site), administration date: 21Jan2021, for Covid-19 Immunization, reaction(s) pain at injection site. The following information was reported IMMUNISATION (non-serious) with onset 05Dec2021 21:30, outcome unknown, described as Third Shot; VACCINATION SITE PAIN (non-serious) with onset 07Dec2021 06:00, outcome not recovered; LYMPHADENOPATHY (non-serious) with onset 07Dec2021 06:00, outcome not recovered, described as same side as injection arm; LYMPH NODE PAIN (non-serious) with onset 07Dec2021 06:00, outcome not recovered. Therapeutic measures were not taken as a result of vaccination site pain, lymphadenopathy, and lymph node pain.  The patient did not receive any other vaccines within four weeks prior to the vaccination. Patient reported had not diagnosed with COVID-19 prior to the vaccination. Since the vaccination, the patient had not tested for COVID-19. Patient had no other symptoms with the dose 3 vaccine.  Follow-up attempts are completed. No further information is expected.   No follow-up attempts are possible. No further information is expected. Linked Report(s) US-PFIZER INC-202101796151 similar report from same reporter; US-PFIZER INC-202101796133 similar report from same reporter.
Less than one week later sleepiness, weakness. By 2 wk after the vaccination she developed bilat leg weakness and could no longer walk.  She was admitted to hospital 12-6-2008. Was diagnosed with GUILLAIN BARRE syndrome. Follow up received 7/21/2010: She only partially recovered from the Guillain Barre and died at the hospital last year. I do not have access to her chart now and cannot remember the exact date.  8/27/09 Received hospital medical records of 12/6/08-6/23/2009 FINAL DX: acute inflammatory demyelinating polyneuropathy/Guillain-Barre syndrom w/quadriparesis w/respiratory failure, s/p tracheostomy, s/p ventilator, s/p IVIG;  s/p G-tube placement; recurrent UTI due to VRE/Klebsiella; atrial fib s/p pacemaker; acure renal failure, resolved. Records reveal patient experienced acute onset generalized weakness, leg cramps, dyspnea, sleepy, difficulty walking, fall.  Neuro consult done.  Intensive care.  BP dropped, developed dysphagia, atrial fib, areflexic, fever, sepsis, multiple UTIs, decreased mental status, intubated & mech ventilation, bradycardia, DVT right arm,  Tx w/IVIG x 5 doses x 2 courses, blood transfusions, IV antibiotics, pacemaker insertion,  Progress very slow & ultimately d/c to inpatient rehab facility. Principal ICD9 codes: 3570, 34400, 51881, 5990
Recruit with undisclosed PCN allergy received Bicillin. Noted he had patchy rash across chest and back. Received Benadryl 50mg.
Gave shot and immediately patient had a seizure. She was seated and nurse had her hand behind her back holding some of her weight. The nurse noticed her right arm shaking after she dropped her pocket book onto the floor. She didn't respond to the nurse. This lasted 15 seconds approx. The nurse asked if she could get a friends phone number for a lift home. The patient gave it once quickly and the nurse asked for it again as she didn't get it and the patient seized again for 15 seconds. The nurse called 911, but the patient refused to go to the hospital. The patients friend took her home. We tried to call the patient, but could never get a hold of her.
Pt was in a daze, body stiff, eyes rolled to back of head. Pt taken to ER. Pt began to have visual hallucinations, irritability and ataxia. Pt was treated for migraine headache.
on march 2, 2021  was my 2nd shot  I started to get symptoms from the covid shot and they were tiredness, headache, dizziness,  body aches, cold and hot chills, high fever for 4 days. high fever for 3 days   1day- march 2 2day march 3 3day march 4 4 days march 5 and fever keeps going up and down.
The patient had vasovagal reaction due to fear of needle. Patient assisted and attended to as needed per protocol. The patient was placed on flat surface and legs were elevated, cold cool packs provided to patient. Patient regained consciousness after approximate 10 seconds. Patient's vital signs were obtained 3 times every 5 minutes. Vital signs were stable. Patient was provided with water.
w/in 4hr of vax pt devel redness @ the inj site & nausea;pt recovered p/2 to 3 days;
Fatigue; achy; chills; This is a spontaneous report from a contactable other hcp (patient). A 27-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) intramuscularly at left arm on 04Jan2021 14:30 at single dose for COVID-19 immunization. Medical history included known allergies to shellfish. The patient's concomitant medications were not reported. The patient previously took first dose of bnt162b2 for COVID-19 immunization. The patient experienced fatigue, achy, chills, all on 05Jan2021 01:15. No treatment received for the adverse events. This a non-serious report. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the events was recovered in Jan2021.  Information on the lot/batch number has been requested.
Patient is 78 years old with past medical history of COPD, CHF, atrial fibrillation, GERD, coronary artery disease, hyperlipidemia, obstructive sleep apnea, restless leg syndrome, diabetes mellitus type 2 presented to the hospital with a chief complaint of a dry cough associated with malaise and shortness of breath that has been worsening over the last 2 days.  Patient states that one of her family members had COVID but she was not in a recent contact with hand.  Patient was found to have COVID infection.  When seen, patient was resting in bed comfortably.  Otherwise patient has no fever, chills, chest pain, abdominal pain, nausea, vomiting, diarrhea, constipation, difficulty urination, dysuria.  Patient has been generally weak over the last 2 days.   In the ED, patient was given a dose of azithromycin and Decadron.   Clinical Summary Patient tested positive for COVID 9/2 and required supplemental oxygen but was weaned to room air.  Patient did not start remdesivir but did have dexamethasone.  Patient was found to have a 2L NC PRN requirement at discharge.  Patient continues to have a cough but reports feeling well otherwise.  VS and labs have been stable otherwise.  Patient will be discharged home with instructions to follow up with PCP.   Discharge diagnosis COVID infection Cough Malaise Generalized weakness COPD CHF Atrial fibrillation Diabetes Hypothyroidism Hypertension Chronic kidney disease stage III Obstructive sleep apnea Restless leg syndrome History of fibromyalgia Coronary artery disease HFrEF Morbid obesity
This case was reported by a other health professional via sales rep and described the occurrence of adverse reaction in a patient who received BEXSERO (batch number 16D501, expiry date unknown) for prophylaxis. On an unknown date, the patient received BEXSERO. On an unknown date, less than a year after receiving BEXSERO, the patient experienced adverse reaction, injection site pain, injection site erythema, fever and injection site swelling. On an unknown date, the outcome of the adverse reaction, injection site pain, injection site erythema, fever and injection site swelling were unknown.  It was unknown if the reporter considered the adverse reaction, injection site pain, injection site erythema, fever and injection site swelling to be related to BEXSERO. Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that the patient experienced injection site pain, redness, swelling, and fever were beyond typical reactions the reporter had seen in the past and with other products. The reporter stated that, they noticed that it stems from Lot 16D501 from the Vaccines for Children (VFC) program. At the time of this report the reporter was choosing to not use BEXSERO until they receive further information from VFC program and manufacturer medical team. The reporter agreed to be followed up. This is 1 of the 8 cases (8 out of 20 patients reported adverse reactions) reported by same reporter for same event.
The day after above shots were given, patient's face swelled up. Over the next 4 months, his face swelled intermittently for no apparent reason. On July 7, his face and entire body swelled. He was heavier too. His weight went from 42lbs upto 48lbs over 6 days time. Dr saw him over the next 4-5 days and he went to the ER 2x to attempt to restore his kidney function. Patient's blood pressure and weight continued to rise and his urine revealed protein and blood. His other labs were abnormal too. Due to his elevated blood pressure and continued proteinuria, patient was admitted to Hospital. With a diagnosis of Nephrotic Syndrome. He was an inpatient there from July 13-16. His Blood pressure and swelling have resolved and his urine is free from protein as of today 7/20/17. He will require continued Dr visits with a Pediatric Nephrologist and 12 weeks of steroids and urine checks.
Approximately a week after the shot, it felt like my ears were off. After another week of determining it was not congestion - I had taken some otc meds and then over the weekend took some Afrin, nothing changed. I noticed a distinct difference when I turned the water on - my left ear was markedly different than normal. Made an appointment with audiologist and saw her on May 20th.  In hindsight, I was turning the volume up to full on my ear buds during this time - never had done this before. I have had a history of ringing in the ears prior to the shot; however, ringing sensation is worse than before.
Information was received from a pharmacist concerning an unspecified number of patients (demographics not provided). The pharmacist reported that an unspecified number of unspecified patients are "routinely revaccinated with PNEUMOVAX-23 every 5 years" (dates of vaccination, dosages and routes of administration not provided). No adverse effect reported. Additional information has been requested.
Patient's husband reported signs of "throat and lungs feeling raw, difficult breathing, coughing, watery & itching eyes"
ALLERGIC REACTION; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 03-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the patient experienced allergic reaction. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of allergic reaction was not reported. This report was non-serious.
Erythematous - sore - swollen right arm chills - no fever. Tired, achy, very fatigued (Put on Zithromycin 25- mg 500 mg 1st day 250 mg 4 days). Painful arm. Seen 9/11/12 & 9/13/12. Doing better on 9/13/12.
Patient received the vaccine and 1:10pm and 5 minutes later she came to the counter to tell us she was feeling dizzy and she fainted.
Patient is an employee at a Pharmacy and at onset of symptoms, was visibly pale, unable to stand or walk without help, and cited having excessive dizziness. Did NOT develop hives, rash, or dyspnea during observation in pharmacy for 2 hours.
patient initially had myalgias and then 5 days after second vaccination patient had acute onset of burning, numbness and tingling of his feed and legs.
Patient received vaccine that was stored post incorrectly post puncture of vial (up to 28 days)
Red, swollen from injection site to elbow (reported 12/15/17  by granddaughter). Given BENADRYL Q6H and ice therapy.
patient complained of lightheadedness, patient initially declined any juice, patient was lowered back in recliner to wait through the 15 minute wait time. After 20 minutes patient agreed to take juice. after wait time of 30 minutes patient felt good to leave.
Moderna vaccine is not indicated for patients under 18. Patient was 16 at the time the vaccine was administered by nurse
severe arm pain; Possible arm injury; Vaccine administered at inappropriate site; This case was reported by a pharmacist via call center representative and described the occurrence of pain in arm in a 66-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced pain in arm, arm injury and vaccine administered at inappropriate site. The patient was treated with narcotics, nos (Narcotics (Unspecified)). On an unknown date, the outcome of the pain in arm, arm injury and vaccine administered at inappropriate site were unknown.   It was unknown if the reporter considered the pain in arm and arm injury to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient presented at the facility's emergency department with severe arm pain and she was treated with narcotics.  The reporter stated that, the patient had reported possible arm injury in their chat and the Shingrix vaccine might had been administered in a patient's joint or synovial fluid in the right arm, which led to intramuscular formulation administered by other route.  The vaccine was administered at a different facility.  The reporter declined and did not gave consent to follow-up. Additional information was unknown.
Patient received only the liquid component of Menveo; Patient received only the liquid component of Menveo; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in a 16-year-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number amva548a, expiry date 28th February 2022) for prophylaxis.   On 19th July 2021, the patient received Menveo. On 19th July 2021, unknown after receiving Menveo, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.  Additional details were provided as follows: The medical assistant called to report patient received only the liquid component of Menveo, which led to  inappropriate preparation of medication and inappropriate dose of vaccine administered. The reporter conented to follow up.
Patient received vaccine 11-15-13. Called 11-18-13 to inform of redness, swelling, rash (about softball size) that started 11-16-13 in the afternoon. Swelling, redness started to subside. Suggested BENADRYL 50mg at bedtime and to contact MD if no improvement. Asked patient to call back, could not reach.
Patient was seen on 3/17/04 for crush injury right finger by the doctor. Patient received a tetanus vaccination. Patient came in on 3/23/04 for follow up with doctor complaining of aching and swelling at injection site, increased when lifting arm above head. On 3/30/04, patient complained of aching decreased swelling at injection site. Follow up 4/14/04. Doctor saw patient 6 days after Td injection for follow up of her crush injury and patient reported that the arm that received the Td injection had muscle stiffness as if she had been working out. It was not swollen or red according to the doctor.
Optic neuritis beginning 10/99 - arthritis starting 8/99; treated with high dose steroids starting 12/99.  Still has vision loss.
Chronic Urticaria since one week after vaccination. Only occurs after waking and late evening.
So about 4/4:30pm the evening of my vaccine I had a low fever, aches and chills that type of thing. Then around 6:30pm I started throwing up continually for several hours. I called someone and at 10:15pm they took me to the ER. They put me on an IV with anti-nausea medication and within 2-3 hours I was feeling better, and they sent me home. Then after that I just had the general not feeling well - the aches, chills, headache. The next day I was not feeling very good still and then the following morning after that I was pretty much back to normal. I don't know if this pertains or not but at the end of May I had a mammogram and I had a lump in my breast and then a couple weeks ago they did more tests and they saw I had an enlarged lymph node, and that is abnormal for me that has happened since my vaccination.
One hour after DTaP, developed rash over head, back and chest. Also erythema to injection site.
Small blisters starting on back of neck, down spine and around trunk. Fever. Ear pain with popping. Sharp pain over eye and nose bridge. Dizziness.
1 week after the second dose, I was exercising in the early morning when suddenly my vision and hand-eye coordination were flashing, my hand appeared in a different position than where I thought it was. I tried to tell my sons to get help, but I couldn't say any words, just some repetitive mumbling. I was able to walk upstairs but couldn't speak for about 10 mins, and then everything was coming out slowly. It was about an hour before I could resume normal talking. I went to the hospital, where they gave me a CT scan, MRI, heart echo, and eventually a TEE. They said that I had a Transient Ischemic Attack, and they found a PFO in my heart that probably allowed a blood clot to travel to my brain.  They also did an ultrasound of my legs when I mentioned the timing of the vaccine, to make sure there were no other clots. I am taking baby asprin and crestor, and have an heart event monitor now for 30 days. I am also scheduled for more bloodwork and a pelvic scan. They say it is likely that they will want to close my PFO, but want to see all the test results first to rule out any other possible causes.
Rash in lower arm, 103 F temperature, swollen lymph nodes in both arms, but more pronounced in right arm. Pt's Dr not sure if swollen nodes are due to vaccines or something else. Dr will send pt to get lab work, ultrasound.
Patient received vaccinations on 7/17 pm. Mother reported no illness or fever. Mother reported normal feeding that evening and in the morning. On 7/18 am, mother reported feeding the baby and then putting in crib after feeding finished. Baby did not move when put in crib and found to be not breathing by mom. 911 called and child was found to be in pulseless arrest. CPR performed for 25 minutes or more before pulse restored in ER. Child has been in PICU with evidence of brain damage since then.
1 week post injection, my injection site began to swell and a red welt has appeared. It is warm to touch.
I started to get cramps in my right leg in a thigh and a calf, came on slowly and got so bad I could not walk. For the last 8 months I have been receiving PT and Acupuncture for it along with taking about Extra Strength Advil. It was getting better but to best, but I could walk but still had a thigh muscle pain. 9 days after the booster I got excruciating pains back in my thigh and my heal of my foot under the ankle. Again I could not walk, and still can't. My doctor with all the help of the below tests cannot diagnose this.
Patient said 4 hours after shot, she had nausea, vomitting, shortness of Breath, lethargic. Her pulse ox dropped to 80. She went to ER to Rule out Food poisoning. She said she Felt like she was having a heart attack. ER MD told her it must have been the flu shot.
Client reports normal evening after vaccination other than a sore arm. Woke up around 1:30 am. " Body shaking, moving around, couldn't control body." "Really cold, teeth chattering. My head felt warm."  He reports watching the clock till around 2:30am and fell asleep. Awoke around 6:30/6:45am with his alarm clock and "felt normal, except sore arm." Now, "maybe a headache, "and wants to know if he can take Tylenol. Informed to notify his PCP and if anything else happens if needed he should seek medical care at Urgent Care Facility if needed.  The client had 1st dose COVID19 Pfizer, April 28, 2021 and had a sore arm.
extreme body ache; intense dizziness; This case was reported by a physician via sales rep and described the occurrence of general body pain in a 61-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 24th October 2019 10:00, the patient received the 1st dose of Shingrix. On 24th October 2019 14:00, 4 hrs after receiving Shingrix, the patient experienced general body pain and dizziness. On 25th October 2019, the outcome of the general body pain and dizziness were recovered/resolved.   It was unknown if the reporter considered the general body pain and dizziness to be related to Shingrix.  Additional details were provided as follows: The patient experienced extreme body ache and intense dizziness which disappeared the next day. The patient was likely to return for the 2nd dose but was less doubtful regarding adverse events with 2nd dose of Shingrix.
Pain, redness, swelling, black line running down arm at site, nausea, diarrhea, stomach pain, hoarseness.
This spontaneous report as received from a registered nurse refers to a currently 1 year old patient of unknown age and unknown gender. Pertinent medical history, drug reactions or allergies were not reported. On 25-AUG-2014 the patient was vaccinated with (Oka-Merck) PROQUAD, 0.5 ml, subcutaneous in the left thigh, lot number K006770, expiration date 07-NOV-2015, for prevention (dose number were unspecified). On an unknown date in August 2014, the patient experienced injection site reactions and swelling after an injection (Oka-Merck) PROQUAD. The patient did not seek medical attention. The outcome of the event was unknown. The relatedness between (Oka-Merck) PROQUAD and the events was not reported. This is one of several reports received from the same reporter. Additional information has been requested.
At 11:00 pm I began having severe chest pain. The pain was so severe I could not draw a deep breath. I went to the ER.
Headache, Myalgia, Fatigue, erythema/enduration at injection site and painful axillary lymph node  Narrative: